Working... Menu

Efficacy of VIUSID® Plus GLIZIGEN® in Patients With Papilloma Virus Esophageal

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03584308
Recruitment Status : Completed
First Posted : July 12, 2018
Last Update Posted : May 22, 2019
Information provided by (Responsible Party):
Catalysis SL

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : May 15, 2018
  Actual Study Completion Date : December 15, 2018